New highlight in breast cancer development: the key role of hepcidin and iron metabolism.
作者信息
Scimeca Manuel, Bonanno Elena
机构信息
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
IRCCS San Raffaele, Rome, Italy.
出版信息
Ann Transl Med. 2018 Nov;6(Suppl 1):S56. doi: 10.21037/atm.2018.10.30.
Abstract
摘要
相似文献
1
New highlight in breast cancer development: the key role of hepcidin and iron metabolism.乳腺癌发展的新亮点：铁调素与铁代谢的关键作用。
Ann Transl Med. 2018 Nov;6(Suppl 1):S56. doi: 10.21037/atm.2018.10.30.
2
Hepcidin: A key regulator of iron.铁调素：铁的关键调节因子。
J Pak Med Assoc. 2019 Aug;69(8):1170-1175.
3
Hepcidin and iron metabolism: from laboratory to clinical implications.亚铁整合素与铁代谢：从实验室到临床意义。
Clin Chim Acta. 2010 Nov 11;411(21-22):1565-9. doi: 10.1016/j.cca.2010.07.003. Epub 2010 Jul 8.
4
Simulated microgravity decreases circulating iron in rats: role of inflammation-induced hepcidin upregulation.模拟微重力降低大鼠循环铁水平：炎症诱导的铁调素上调的作用
Exp Physiol. 2017 Mar 1;102(3):291-298. doi: 10.1113/EP086188.
5
Hepcidin in iron metabolism.铁代谢中的铁调素
Curr Protein Pept Sci. 2005 Jun;6(3):279-91. doi: 10.2174/1389203054065392.
6
The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.亚铁转运蛋白内吞作用的动态变化和新型亚铁转运蛋白疾病突变的后果。
Am J Hematol. 2017 Oct;92(10):1052-1061. doi: 10.1002/ajh.24844. Epub 2017 Jul 29.
7
Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.三维结构和肿瘤相关成纤维细胞对乳腺癌中血红素调节的贡献。
Oncogene. 2018 Jul;37(29):4013-4032. doi: 10.1038/s41388-018-0243-y. Epub 2018 Apr 26.
8
Current status of iron metabolism: Clinical and therapeutic implications.铁代谢的现状：临床及治疗意义
Med Clin (Barc). 2017 Mar 3;148(5):218-224. doi: 10.1016/j.medcli.2016.10.047. Epub 2017 Jan 7.
9
Role of hepcidin and iron metabolism in the onset of prostate cancer.铁调素与铁代谢在前列腺癌发病中的作用。
Oncol Lett. 2018 Jun;15(6):9953-9958. doi: 10.3892/ol.2018.8544. Epub 2018 Apr 20.
10
Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.早期乳腺癌患者的血浆铁调素：与白细胞介素-6、促红细胞生成素和促红细胞生成素铁蛋白无关。
Expert Rev Proteomics. 2015;12(6):695-701. doi: 10.1586/14789450.2015.1099436. Epub 2015 Oct 23.
引用本文的文献
1
Serum Hepcidin Levels in Breast Cancer Patients: Investigating the Correlation to Tumor Stage-A Cross-Sectional Study.乳腺癌患者的血清铁调素水平：探究与肿瘤分期的相关性——一项横断面研究
Health Sci Rep. 2025 Aug 10;8(8):e71148. doi: 10.1002/hsr2.71148. eCollection 2025 Aug.
2
Iron chelators in breast cancer therapy: mechanisms and clinical applications - a narrative review.乳腺癌治疗中的铁螯合剂：作用机制与临床应用——一篇叙述性综述
Ann Med Surg (Lond). 2025 Apr 25;87(6):3556-3565. doi: 10.1097/MS9.0000000000003296. eCollection 2025 Jun.
3
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.靶向起始因子以激活铁死亡和铜死亡用于乳腺癌治疗：临床应用的进展与可能性
Front Pharmacol. 2025 Jan 10;15:1493188. doi: 10.3389/fphar.2024.1493188. eCollection 2024.
4
Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer.探索免疫相关特征的新型簇及其预后价值，并确定HAMP作为结直肠癌中的关键基因。
Oncol Lett. 2023 Jul 5;26(2):360. doi: 10.3892/ol.2023.13946. eCollection 2023 Aug.
5
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial-Mesenchymal Transition and Correlates with Progression of the Disease.结直肠癌中hepcidin上调与调节性巨噬细胞的积累和上皮-间质转化相关，并与疾病进展相关。
Cancers (Basel). 2022 Oct 27;14(21):5294. doi: 10.3390/cancers14215294.
6
An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System.铁调素在男性泌尿生殖系统常见恶性肿瘤中的综合系统分析及临床意义
Front Genet. 2022 May 12;13:771344. doi: 10.3389/fgene.2022.771344. eCollection 2022.
7
Pre-Clinical Insights into the Iron and Breast Cancer Hypothesis.铁与乳腺癌假说的临床前见解
Biomedicines. 2021 Nov 9;9(11):1652. doi: 10.3390/biomedicines9111652.
8
Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration.肺癌中 hepcidin 的上调：与免疫浸润相关的潜在治疗靶点。
Front Immunol. 2021 Apr 1;12:612144. doi: 10.3389/fimmu.2021.612144. eCollection 2021.
9
Iron: An Essential Element of Cancer Metabolism.铁：癌症代谢的必需元素。
Cells. 2020 Dec 3;9(12):2591. doi: 10.3390/cells9122591.
10
Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer.炎症介导的铁调素-铁转运蛋白途径及其在乳腺癌中的治疗窗口期
Breast Cancer (Dove Med Press). 2020 Oct 20;12:165-180. doi: 10.2147/BCTT.S276404. eCollection 2020.
本文引用的文献
1
Insights into Trace Metal Metabolism in Health and Disease from PET: "PET Metallomics".从 PET 看健康与疾病中的痕量金属代谢：“PET 金属组学”。
J Nucl Med. 2018 Sep;59(9):1355-1359. doi: 10.2967/jnumed.118.212803. Epub 2018 Jul 5.
2
Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.上皮间质转化和癌症干细胞导致乳腺癌异质性。
J Cell Physiol. 2018 Dec;233(12):9136-9144. doi: 10.1002/jcp.26847. Epub 2018 Jul 3.
3
Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological Significance.乳腺微钙化的放射学、组织学及化学分析：诊断价值与生物学意义
J Mammary Gland Biol Neoplasia. 2018 Jun;23(1-2):89-99. doi: 10.1007/s10911-018-9396-0. Epub 2018 May 9.
4
Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.三维结构和肿瘤相关成纤维细胞对乳腺癌中血红素调节的贡献。
Oncogene. 2018 Jul;37(29):4013-4032. doi: 10.1038/s41388-018-0243-y. Epub 2018 Apr 26.
5
Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork.数字时代肿瘤患者的管理：解剖病理学与核医学团队协作。
Future Oncol. 2018 May;14(11):1013-1015. doi: 10.2217/fon-2017-0698. Epub 2018 Apr 6.
6
Energy Dispersive X-ray (EDX) microanalysis: A powerful tool in biomedical research and diagnosis.能量色散X射线（EDX）微分析：生物医学研究与诊断中的一项强大工具。
Eur J Histochem. 2018 Mar 15;62(1):2841. doi: 10.4081/ejh.2018.2841.
7
Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.乳腺成骨细胞样细胞：乳腺癌骨转移的可靠早期标志物。
Clin Breast Cancer. 2018 Aug;18(4):e659-e669. doi: 10.1016/j.clbc.2017.11.020. Epub 2017 Dec 5.
8
Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis.人类癌症中的成骨细胞样细胞：骨转移的新细胞类型和可靠标志物。
Future Oncol. 2018 Jan;14(1):9-11. doi: 10.2217/fon-2017-0472. Epub 2017 Dec 8.
9
Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis.破骨细胞中 PTX3 表达的损伤：骨质疏松症的一个关键因素。
Cell Death Dis. 2017 Oct 12;8(10):e3125. doi: 10.1038/cddis.2017.514.
10
PTX3: a new mediator of bone metabolism and osteoporosis.PTX3：骨代谢与骨质疏松症的一种新介质
Muscles Ligaments Tendons J. 2017 May 10;7(1):200-201. doi: 10.11138/mltj/2017.7.1.200. eCollection 2017 Jan-Mar.
Zotero 插件